BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 9062191)

  • 21. 'Zip codes' direct intracellular protein tyrosine phosphatases to the correct cellular 'address'.
    Mauro LJ; Dixon JE
    Trends Biochem Sci; 1994 Apr; 19(4):151-5. PubMed ID: 8016862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiological function of receptor-SH2 interactions.
    Ponzetto C
    Curr Top Microbiol Immunol; 1998; 228():165-77. PubMed ID: 9401206
    [No Abstract]   [Full Text] [Related]  

  • 23. Identifying Transmembrane Interactions in Receptor Protein Tyrosine Phosphatase Homodimerization and Heterodimerization.
    Rizzo S; Thévenin D
    Methods Mol Biol; 2024; 2743():195-209. PubMed ID: 38147217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Redox regulation of signal transduction in mammalian cells.
    Herrlich P; Böhmer FD
    Biochem Pharmacol; 2000 Jan; 59(1):35-41. PubMed ID: 10605932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Switching signals on or off by receptor dimerization.
    Weiss A; Schlessinger J
    Cell; 1998 Aug; 94(3):277-80. PubMed ID: 9708728
    [No Abstract]   [Full Text] [Related]  

  • 26. High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-1 in macrophages.
    Veillette A; Thibaudeau E; Latour S
    J Biol Chem; 1998 Aug; 273(35):22719-28. PubMed ID: 9712903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mouse and human SHPS-1: molecular cloning of cDNAs and chromosomal localization of genes.
    Yamao T; Matozaki T; Amano K; Matsuda Y; Takahashi N; Ochi F; Fujioka Y; Kasuga M
    Biochem Biophys Res Commun; 1997 Feb; 231(1):61-7. PubMed ID: 9070220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone regulation of SIRP and SHP-2 tyrosyl phosphorylation and association.
    Stofega MR; Wang H; Ullrich A; Carter-Su C
    J Biol Chem; 1998 Mar; 273(12):7112-7. PubMed ID: 9507023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities.
    Yin N; Li X; Zhang X; Xue S; Cao Y; Niedermann G; Lu Y; Xue J
    Signal Transduct Target Ther; 2024 May; 9(1):126. PubMed ID: 38773064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress in cancer research on the regulator of phagocytosis CD47, which determines the fate of tumor cells (Review).
    Wu F; Pang H; Li F; Hua M; Song C; Tang J
    Oncol Lett; 2024 Jun; 27(6):256. PubMed ID: 38646501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction.
    Vaccaro K; Allen J; Whitfield TW; Maoz A; Reeves S; Velarde J; Yang D; Meglan A; Ribeiro J; Blandin J; Phan N; Bell GW; Hata AN; Weiskopf K
    J Clin Invest; 2024 Mar; 134(9):. PubMed ID: 38483480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbon Ion Irradiation Activates Anti-Cancer Immunity.
    Sudo M; Tsutsui H; Fujimoto J
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The nuclear factor ID3 endows macrophages with a potent anti-tumour activity.
    Deng Z; Loyher PL; Lazarov T; Li L; Shen Z; Bhinder B; Yang H; Zhong Y; Alberdi A; Massague J; Sun JC; Benezra R; Glass CK; Elemento O; Iacobuzio-Donahue CA; Geissmann F
    Nature; 2024 Feb; 626(8000):864-873. PubMed ID: 38326607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery and Preclinical Activity of BMS-986351, an Antibody to SIRPα That Enhances Macrophage-mediated Tumor Phagocytosis When Combined with Opsonizing Antibodies.
    Chan H; Trout CV; Mikolon D; Adams P; Guzman R; Mavrommatis K; Abbasian M; Hadjivassiliou H; Dearth L; Fox BA; Sivakumar P; Cho H; Hariharan K
    Cancer Res Commun; 2024 Feb; 4(2):505-515. PubMed ID: 38319147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phagocytosis-initiated tumor hybrid cells acquire a c-Myc-mediated quasi-polarization state for immunoevasion and distant dissemination.
    Chou CW; Hung CN; Chiu CH; Tan X; Chen M; Chen CC; Saeed M; Hsu CW; Liss MA; Wang CM; Lai Z; Alvarez N; Osmulski PA; Gaczynska ME; Lin LL; Ortega V; Kirma NB; Xu K; Liu Z; Kumar AP; Taverna JA; Velagaleti GVN; Chen CL; Zhang Z; Huang TH
    Nat Commun; 2023 Oct; 14(1):6569. PubMed ID: 37848444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Host-directed therapy for bacterial infections -Modulation of the phagolysosome pathway.
    Taya T; Teruyama F; Gojo S
    Front Immunol; 2023; 14():1227467. PubMed ID: 37841276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A frameshift variant in the
    Tang J; Wan X; Zhang J; Diao N; Zhang C; Gao X; Ren D
    Front Genet; 2023; 14():1130529. PubMed ID: 37323681
    [No Abstract]   [Full Text] [Related]  

  • 38. A MD Simulation Prediction for Regulation of
    Zhao Y; Fang L; Guo P; Fang Y; Wu J
    Molecules; 2023 May; 28(10):. PubMed ID: 37241964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure, Function, and Molecular Landscapes of the Aging Retina.
    Zhu JD; Tarachand SP; Abdulwahab Q; Samuel MA
    Annu Rev Vis Sci; 2023 Sep; 9():177-199. PubMed ID: 37196423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic effect of CD47 blockade in combination with cordycepin treatment against cancer.
    Feng C; Chen R; Fang W; Gao X; Ying H; Zheng X; Chen L; Jiang J
    Front Pharmacol; 2023; 14():1144330. PubMed ID: 37138855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.